Outcome Study of Double Bare Stent for Malignant Gastric Outlet Obstruction
Phase IV Study of Double Bare Self-expandable Metallic Stent for Malignant Gastric Outlet Obstruction
1 other identifier
interventional
49
1 country
1
Brief Summary
Self-expandable metallic stents provide effective palliation of malignant gastric outlet obstruction. However, uncovered stent are often associated with re-stenosis caused by tumor in-growth through the stent mesh. The Self-expandable metallic stents which has the design of smaller wire mesh size (double bare stent) were developed and used in Korea. This new design was developed to minimize the re-stenosis of uncovered stent, but the outcome is unknown. The end point of this study is the 8-weeks patency rate after placement of double bare as well as technical and clinical success rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2013
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 2, 2014
CompletedFirst Posted
Study publicly available on registry
June 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedJune 5, 2014
June 1, 2014
2.5 years
June 2, 2014
June 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The patency rate at 8 weeks after placement.
8 weeks
Secondary Outcomes (3)
Technical and clinical success rates
up to 8 weeks
re-stenosis rate
8 weeks
migration rate
8 weeks
Study Arms (1)
DoubleBare stent
EXPERIMENTALPlacement of double bare stent
Interventions
Eligibility Criteria
You may qualify if:
- Malignant gastric outlet obstruction
- Symptoms compatible with gastric outlet obstruction
- An inoperable condition because of extent of disease or patient's conditions
You may not qualify if:
- History of enteral stent placement, undergone gastric surgery.
- Additional small bowel stenosis distal to gastric outlet obstruction.
- Refuse to be enrolled to study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cancer Center
Goyang-si, Gyeonggi-do, 410-769, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior scientist
Study Record Dates
First Submitted
June 2, 2014
First Posted
June 5, 2014
Study Start
January 1, 2013
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
June 5, 2014
Record last verified: 2014-06